BARD1
Company Overview
Industries
Social Media Profiles
About BARD1
Description
BARD1 is a biotechnology company focused on developing innovative diagnostic solutions for cancer detection. With a commitment to enhancing patient outcomes, BARD1 leverages its proprietary technology to create non-invasive blood tests, aiming to provide early diagnostic capabilities for various cancers, thereby revolutionizing cancer management.
Specialties
Non-invasive blood tests
Early cancer detection
Proprietary diagnostic technology
Innovative cancer management
Diagnostic solutions for healthcare
Products & Services
Cancer diagnostic tests
Non-invasive blood tests
hTERT test
EXO-NET® tool
Research-stage cancer tests
Contact Information
No contact information available
Competitors & Similar Companies(5)
Guardant Health
GRAIL
Exact Sciences
Foundation Medicine
Caris Life Sciences
News & Media
Search Terms:
bard1
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about BARD1
Where is BARD1 located?
The headquarter of BARD1 is located in Notting Hill, Victoria, Australia
What is the official website of BARD1?
The official website of BARD1 is https://www.bard1.com
What industry does BARD1 belong to?
BARD1 belongs to the Pharmaceuticals industry.
What are the specialties of BARD1?
BARD1 specializes in Non-invasive blood tests, Early cancer detection, Proprietary diagnostic technology, Innovative cancer management, Diagnostic solutions for healthcare.
What products and services is BARD1 likely to offer?
BARD1 offers Cancer diagnostic tests, Non-invasive blood tests, hTERT test, EXO-NET® tool, Research-stage cancer tests.
Who are the competitors of BARD1?
Competitors of BARD1 are Guardant Health, GRAIL, Exact Sciences, Foundation Medicine, Caris Life Sciences.
What does BARD1 do?
BARD1 is a biotechnology company focused on developing innovative diagnostic solutions for cancer detection. With a commitment to enhancing patient outcomes, BARD1 leverages its proprietary technology to create non-invasive blood tests, aiming to provide early diagnostic capabilities for various cancers, thereby revolutionizing cancer management.